In our recent study using a syngeneic mouse model with B16F10 melanoma cells stably expressing ULBP2, we demonstrated that surface ULBP2 promotes tumor growth by suppressing NK cell-mediated immunity through NKG2D [45]. The gene discussed is KLRK1; the disease is neoplasm.